Supplementary Figure 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244) Article Swipe
Related Concepts
Selumetinib
MEK inhibitor
Addiction
Computer science
Computational biology
Psychology
Biology
Genetics
Neuroscience
MAPK/ERK pathway
Signal transduction
Jonathan R. Dry
,
Sandra Pavey
,
Christine A. Pratilas
,
Chris Harbron
,
Sarah Runswick
,
Darren Hodgson
,
Christine M. Chresta
,
Rose McCormack
,
Natalie Byrne
,
Mark Cockerill
,
Alexander Graham
,
Garry Beran
,
Andrew Cassidy
,
Carolyn Haggerty
,
Helen Brown
,
Gillian Ellison
,
Judy Dering
,
Barry S. Taylor
,
Mitchell Stark
,
Vanessa Bonazzi
,
Sugandha Ravishankar
,
Leisl Packer
,
Feng Xing
,
David B. Solit
,
Richard S. Finn
,
Neal Rosen
,
Nicholas K. Hayward
,
Tim French
,
Paul D. Smith
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22386785.v1
· OA: W4362460402
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22386785.v1
· OA: W4362460402
Supplementary Figure 3 from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Related Topics
Finding more related topics…